171 related articles for article (PubMed ID: 18631314)
21. Treatment. Antiretroviral adherence results in lower health care costs, study says.
AIDS Policy Law; 2010 Feb; 25(3):1. PubMed ID: 20419883
[No Abstract] [Full Text] [Related]
22. Initiating antiretroviral therapy for HIV at a patient's first clinic visit: a cost-effectiveness analysis of the rapid initiation of treatment randomized controlled trial.
Long LC; Maskew M; Brennan AT; Mongwenyana C; Nyoni C; Malete G; Sanne I; Fox MP; Rosen S
AIDS; 2017 Jul; 31(11):1611-1619. PubMed ID: 28463879
[TBL] [Abstract][Full Text] [Related]
23. The household costs of health care in rural South Africa with free public primary care and hospital exemptions for the poor.
Goudge J; Gilson L; Russell S; Gumede T; Mills A
Trop Med Int Health; 2009 Apr; 14(4):458-67. PubMed ID: 19254274
[TBL] [Abstract][Full Text] [Related]
24. The burden of HIV-related illness on outpatient health services in KwaZulu-Natal, South Africa.
Veenstra N; Oyier A
AIDS Care; 2006 Apr; 18(3):262-8. PubMed ID: 16546788
[TBL] [Abstract][Full Text] [Related]
25. Cost of managed HIV care remains stable, study says.
AIDS Policy Law; 1998 Oct; 13(19):15. PubMed ID: 11365949
[TBL] [Abstract][Full Text] [Related]
26. Establishing a workplace antiretroviral therapy programme in South Africa.
Charalambous S; Grant AD; Day JH; Pemba L; Chaisson RE; Kruger P; Martin D; Wood R; Brink B; Churchyard GJ
AIDS Care; 2007 Jan; 19(1):34-41. PubMed ID: 17129856
[TBL] [Abstract][Full Text] [Related]
27. Cost of medical care, once falling, may be starting to rise again.
AIDS Policy Law; 1999 Oct; 14(20):5. PubMed ID: 11367061
[TBL] [Abstract][Full Text] [Related]
28. Assessing efficiency and costs of scaling up HIV treatment.
Cleary SM; McIntyre D; Boulle AM
AIDS; 2008 Jul; 22 Suppl 1():S35-42. PubMed ID: 18664951
[TBL] [Abstract][Full Text] [Related]
29. Public-sector ART in the Free State Province, South Africa: community support as an important determinant of outcome.
Wouters E; Van Damme W; Van Loon F; van Rensburg D; Meulemans H
Soc Sci Med; 2009 Oct; 69(8):1177-85. PubMed ID: 19692165
[TBL] [Abstract][Full Text] [Related]
30. Cost and resource use of patients on antiretroviral therapy in the urban and semiurban public sectors of South Africa.
Meyer-Rath G; Miners A; Santos AC; Variava E; Venter WD
J Acquir Immune Defic Syndr; 2012 Nov; 61(3):e25-32. PubMed ID: 22895437
[TBL] [Abstract][Full Text] [Related]
31. Impact of baseline health and community support on antiretroviral treatment outcomes in HIV patients in South Africa.
Wouters E; Van Damme W; van Rensburg D; Meulemans H
AIDS; 2008 Nov; 22(18):2545-8. PubMed ID: 19005281
[TBL] [Abstract][Full Text] [Related]
32. Differences in normal activities, job performance and symptom prevalence between patients not yet on antiretroviral therapy and patients initiating therapy in South Africa.
Rosen S; Ketlhapile M; Sanne I; Desilva MB
AIDS; 2008 Jul; 22 Suppl 1():S131-9. PubMed ID: 18664945
[TBL] [Abstract][Full Text] [Related]
33. The public health approach to antiretroviral treatment (ART) service scale-up in Ethiopia: the first two years of free ART, 2005-2007.
Assefa Y; Kloos H
Ethiop Med J; 2008 Oct; 46(4):401-6. PubMed ID: 19271406
[TBL] [Abstract][Full Text] [Related]
34. Antiretroviral therapy and HIV prevention in India: modeling costs and consequences of policy options.
Over M; Marseille E; Sudhakar K; Gold J; Gupta I; Indrayan A; Hira S; Nagelkerke N; Rao AS; Heywood P
Sex Transm Dis; 2006 Oct; 33(10 Suppl):S145-52. PubMed ID: 17003679
[TBL] [Abstract][Full Text] [Related]
35. Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.
Ghatnekar O; Alvegård T; Conradi N; Lenhoff S; Mellqvist UH; Persson U; Löthgren M
Clin Ther; 2008 Sep; 30(9):1704-13. PubMed ID: 18840377
[TBL] [Abstract][Full Text] [Related]
36. The impact of AIDS on government service delivery: the case of the Zambia Wildlife Authority.
Rosen S; Hamazakaza P; Feeley F; Fox M
AIDS; 2007 Jul; 21 Suppl 3():S53-9. PubMed ID: 17666962
[TBL] [Abstract][Full Text] [Related]
37. Implementing antiretroviral therapy in rural communities: the Lusikisiki model of decentralized HIV/AIDS care.
Bedelu M; Ford N; Hilderbrand K; Reuter H
J Infect Dis; 2007 Dec; 196 Suppl 3():S464-8. PubMed ID: 18181695
[TBL] [Abstract][Full Text] [Related]
38. Costs and benefits of HAART for patients with HIV in a public hospital in Mexico.
Aracena-Genao B; Navarro JO; Lamadrid-Figueroa H; Forsythe S; Trejo-Valdivia B
AIDS; 2008 Jul; 22 Suppl 1():S141-8. PubMed ID: 18664946
[TBL] [Abstract][Full Text] [Related]
39. Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness.
Desai K; Sansom SL; Ackers ML; Stewart SR; Hall HI; Hu DJ; Sanders R; Scotton CR; Soorapanth S; Boily MC; Garnett GP; McElroy PD
AIDS; 2008 Sep; 22(14):1829-39. PubMed ID: 18753932
[TBL] [Abstract][Full Text] [Related]
40. Can differentiated care models solve the crisis in HIV treatment financing? Analysis of prospects for 38 countries in sub-Saharan Africa.
Barker C; Dutta A; Klein K
J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21648. PubMed ID: 28770597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
